XML 100 R85.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Instruments and Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Interest income   $ 6.0 $ 12.0 $ 9.4
Impairment charges   10.6 $ 0.0 $ 2.5
Cost of Sales        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Impairment charges   6.3    
Research and development expense        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Impairment charges   $ 4.3    
Customer Concentration Risk | Revenues | Three Customers in Aggregate        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Concentration risk percentage   41.50% 41.30% 40.20%
Customer Concentration Risk | Accounts Receivable | One Customer        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Concentration risk percentage 11.20%